345
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Progress In Radiotherapy

Pages 1023-1029 | Received 30 Aug 1995, Accepted 08 Sep 1995, Published online: 08 Jul 2009

References

  • European Strategy for Cancer Research, Commission of the European Communities, DG‐XII‐Medical Division. Xll/F‐6/ AV/91001P.
  • Wambersie A, Whitniore G F. Radiation therapy. ICRU News x‐ray centenary issue. 1995; 1: 15–20
  • Landberg T. Progress in cancer treatment: Radiotherapy. Oxford Textbook of Oncology. 1995
  • International Commission on Radiation Units and Measurements. ICRU Report No. 50. Prescribing. recording. and reporting photon beam therapy. ICRLJ, Washington DC 1993
  • Larson S, Macapinlac H, Scott A, Divgi C. Recent achievements in the development of radiolabelled monoclonal antibodies for diagnosis. therapy and biologic characterization of human tumours. Acta Oncol 1993; 32: 709–15
  • Wilson G, McNally N, Dische S, et al. Measurements of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry. Br J Cancer 1988; 58: 423–31
  • West C, Davidson S, Hendry J, Hunter R. Prediction of cervical carcinoma response to radiotherapy. Lancet 1991; 338: 818
  • Taylor A, Harnden D, Arlett C, et al. Ataxia‐telangiectasia: a human mutation with abnormal radiation sensitivity. Nature 1975; 258: 427–9
  • Nordsmark M, Rentzen S, Overgaard J. Measurement of human tuniour oxygenation status by a polarographic needle electrode. An analysis of inter‐ and intra tumour heterogeneity. Acta Oncol 1994; 33: 383–9
  • Medical Electron Accelerators, C Karzmark, C Nunan, E Tanabe. McGraw Hill. 1993
  • Proceedings. Meeting, Washington DCUSA, December, 6–101993, C Borrás, of an Advisory Group on the Design Requirements for Megavoltage x‐ray Machines for Cancer Treatment in Developing Countries. World Health Organization and Pan American Health Organization. 1995 (in press)
  • Nette P, Svensson H. Radiation dosimetry in health care: Expanding the reach of global networks. IAEA Bulletin 1994; 4: 33–6
  • Ulsø N, Christensen J. Compensation filters in CT‐scan based on dose planning systems. Br J Radiol 1981, suppl. 15: 122–5
  • Rrahme A. Optimization of stationary and moving beam radiation therapy techniques. Radiother Oncol 1988; 12: 129–40
  • Olsson L, Petersson S, Ahlgren L, Mattsson S. Ferrous sulphate gels for determination of absorbed dose distributions using MRI technique: basic studies. Phys Med Biol 1989; 34: 43–52
  • Hadrontherapy in oncology. International Congress Series 1077. Proceedings of the First International Symposium on Hadrontherapy. Conio, Italy. 18–21 October. 1903, ConioItaly, October, 18–211903, U Anialdi, B Larsson. Elsevier, Excerpta Medica, 1994
  • Thanies H, Withers H, Peters L, Fletcher G. Changes in early and late radiation responses with altered dose fractionation. implications for dose survival relationships. Int J Radial Oncol Biol Phys 1982; 8: 219–26
  • Overgaard M. Spontaneous radiation‐induced rib fractures in breast cancer patients treated with postmastectomy irradiation. A clinical radiobiological analysis of the influence of fraction six and dose‐response relationships on late bone damage. Acta Oncol 1988; 27: 117–22
  • Overgaard J, Horsman M. Overcoming hypoxic cell radio resistance. Basic clinical radiobiology lor radiation oncologists, G Steel. Edward Arnold, London 1993; 163–72
  • Withers H, Taylor J, Maciejewski B. The hazard of accclerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988; 27: 131–46
  • Bentzen S, Overgaard J, Thanies H, et al. J. Clinical radiohiology of malignant melanoma. Radiother Oncol 1989; 16: 169–82
  • Horiot J, Le Fur R, N'Guyen T, et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 1992; 25: 231–41
  • Dische S, Saunders M. The rationale for continuous. hyperfractionated accelerated radiotherapy (CHART). Int J Radiat Oncol Biol Phys 1990; 19: 1317–20
  • Bentzen S, Overgaard M, Thomes H, Christensen J, Overgaard J. Early and late normal‐tissue injury after postmastectomy radiotherapy alone or combined with chemotherapy. Int J Radiat Oncol 1989; 56: 711–5
  • Lindholm C ‐E, Kjellén E, Nilsson P, Weber L, Hill S. Prognostic factors for tumour response and skin damage to combined radiotherapy and hypertherniia in superficial recurrent breast carcinomas. Iiit J Hyperthermia 1995; 5: 337–55
  • Holmberg O, Huizenga H, Idzes M, Lebesque M, Vijlbrief R, Mijnheer R. In vivo determination of the accuracy of field matching in breast cancer irradiation using an electronic portal imaging device. Radiother Oncol 1994; 33: 157–66
  • Brahme A, Chavaudra J, McCullough E, et al. Accuracy requirements and quality assurance of external beam therapy with photons and electrons. Acta Oncol 1988; 27(Suppl. 1)
  • Ahlgren L, Linden M, Mattsson S. A technique for ‘in vivo’ determination of total body and tumour protein in cancer patients. Proceedings. Varian Users Meetiang. Montreaux. May, 9–131993, 67–69
  • Dische S, Saunders M, Williams C, Hopkina A, Aird E. Precision in reporting the dose given in a course of radiotherapy. Radiother Oncol 1993; 29: 287–93
  • Landberg T, Nilsson M. Variability of dose specification in external beam therapy. Editorial, Radiother Oncol 1993; 29: 285–6
  • Nilsson M, Landberg T. Dose specification with 3‐D dose planning (ICRU ‘Level 3’). Acta Oncol 1994; 33: 471–6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.